Scarica l'app Stockscreener
10.55
1.13%
0.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.45
Aprire:
$10.45
Volume 24 ore:
367.28K
Relative Volume:
0.45
Capitalizzazione di mercato:
$371.85M
Reddito:
$2.07M
Utile/perdita netta:
$-47.68M
Rapporto P/E:
-3.7411
EPS:
-2.82
Flusso di cassa netto:
$-31.31M
1 W Prestazione:
+4.63%
1M Prestazione:
+8.06%
6M Prestazione:
-13.66%
1 anno Prestazione:
-14.08%
Intervallo 1D:
$10.42
$10.86
Intervallo di 1 settimana:
$9.69
$10.86
Portata 52W:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Nome
Delcath Systems Inc
Settore
Industria
Telefono
(518) 743-8892
Indirizzo
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Confronta DCTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.53 | 369.03M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
127.09 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.88 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Craig Hallum | Buy |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2022-07-26 | Ripresa | Canaccord Genuity | Buy |
| 2021-12-10 | Iniziato | H.C. Wainwright | Buy |
| 2021-03-09 | Iniziato | Canaccord Genuity | Buy |
| 2021-01-05 | Iniziato | BTIG Research | Buy |
| 2020-06-01 | Iniziato | Laidlaw | Buy |
Mostra tutto
Delcath Systems Inc Borsa (DCTH) Ultime notizie
Under the Radar: 3 Microcap Growers Passing a Tough Test - Benzinga
(DCTH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors? - Yahoo Finance
Are options traders betting on a big move in Delcath Systems stock? - MSN
Delcath Systems Inc Stock Analysis and ForecastLong-Term Growth Stocks & Fast Growing Investment Plans - earlytimes.in
Hepzato Kit Safe, Effective in Metastatic, Unresectable Uveal Melanoma - Cure Today
Are Options Traders Betting on a Big Move in Delcath Systems Stock? - Yahoo Finance
Delcath Systems publishes results from subgroup analyses of FOCUS study - Yahoo Finance
Delcath’s HEPZATO shows consistent efficacy across patient subgroups By Investing.com - Investing.com Nigeria
Delcath’s HEPZATO shows consistent efficacy across patient subgroups - Investing.com India
Delcath Systems (DCTH) Reveals Key Findings from FOCUS Study Sub - GuruFocus
Which metastatic uveal melanoma patients gain most from a liver-directed drug? - Stock Titan
Simplify Asset Management Inc. Increases Stock Position in Delcath Systems, Inc. $DCTH - MarketBeat
Glenmark Pharmaceuticals Limited (532296) Gets Regulatory ApprovalFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Book value per share of Delcath Systems, Inc. – MUN:DV3R - TradingView — Track All Markets
Bearish Setup: Is Delcath Systems Inc stock a smart buy before Fed meetingTrade Entry Summary & Advanced Technical Signal Analysis - moha.gov.vn
Precision Trading with Delcath Systems Inc. (DCTH) Risk Zones - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% - Yahoo Finance
Delcath Systems (STU:DV3R) EV-to-OCF : 19.88 (As of Dec. 21, 2025) - GuruFocus
Why Delcath Systems Inc. (DV3R) stock stays on buy lists2025 Biggest Moves & Entry Point Strategy Guides - bolumsonucanavari.com
Delcath Systems Earnings Notes - Trefis
Delcath Systems authorizes $25 million share repurchase program - MSN
Can Delcath Systems Inc. (DV3R) stock hold up in economic slowdownCEO Change & Risk Controlled Daily Trade Plans - Bölüm Sonu Canavarı
Do Options Traders Know Something About Delcath Systems Stock We Don't? - MSN
Will Delcath Systems Inc. (DV3R) stock sustain bullish trend into 2025Inflation Watch & Long-Term Safe Return Strategies - DonanımHaber
Is Delcath Systems Inc. stock a safe haven assetPortfolio Return Report & Reliable Intraday Trade Plans - Улправда
Will Delcath Systems Inc. stock sustain high P E ratiosPortfolio Profit Report & Expert-Curated Trade Recommendations - Улправда
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Here’s What Hit Delcath Systems (DCTH) in Q3 - Insider Monkey
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing - Stock Traders Daily
Vivo Capital LLC Decreases Stake in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates - sharewise.com
How higher bond yields impact Delcath Systems Inc. (DV3R) stock2025 Key Highlights & High Conviction Investment Ideas - Newser
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and Champions Oncology (CSBR) - The Globe and Mail
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
Why Delcath Systems Inc. (DV3R) stock trades below fair valueQuarterly Trade Report & Daily Stock Trend Reports - Newser
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma - BioSpace
Delcath reports 29-month survival in liver cancer treatment study - Investing.com India
Delcath reports 29-month survival in liver cancer treatment study By Investing.com - Investing.com Nigeria
Delcath Systems (DCTH) Showcases Promising Study Results for Liv - GuruFocus
Is Delcath Systems Inc. stock a top pick in earnings seasonJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years - Yahoo Finance
(DCTH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Delcath Systems (DCTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Delcath Systems (DCTH) Competitors and Alternatives 2025 - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Dir Sylvester Buys 4,386 ($39K) Of Delcath Sys Inc [DCTH] - TradingView
Delcath Systems Inc Azioni (DCTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):